Pacific Heights Asset Management LLC Gilead Sciences, Inc. Transaction History

Pacific Heights Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $3.4 Million - $3.87 Million	-60,000 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $1.45 Million - $1.68 Million	-20,000 Reduced 25.0%	60,000 $4.62 Million
Q4 2019 Jan 27, 2020	SELL	$61.62 - $67.78 $308,100 - $338,900	-5,000 Reduced 5.88%	80,000 $5.2 Million
Q3 2019 Oct 30, 2019	SELL	$62.51 - $69.0 $125,020 - $138,000	-2,000 Reduced 2.3%	85,000 $5.39 Million
Q1 2019 Apr 25, 2019	SELL	$62.53 - $70.05 $1.25 Million - $1.4 Million	-20,000 Reduced 18.69%	87,000 $5.66 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $7.72 Million - $9.15 Million	107,000	107,000 $8.67 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Pacific Heights Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Pacific Heights Asset Management LLC with notifications on news.